Cargando…
Inhibition of Pol I Transcription a New Chance in the Fight Against Cancer
While new cancer treatments continue to improve patient outcomes, for some cancers there have been limited or no improvements for a long time. It is for these cases radically new approaches are required. Recent publications proposing ribosome biogenesis, in particular RNA polymerase I transcription,...
Autores principales: | Hein, Nadine, Hannan, Kathrine M., D'Rozario, James, Hannan, Ross |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5762094/ http://dx.doi.org/10.1177/1533034617744955 |
Ejemplares similares
-
A novel role for the Pol I transcription factor UBTF in maintaining genome stability through the regulation of highly transcribed Pol II genes
por: Sanij, Elaine, et al.
Publicado: (2015) -
How Nutrition can help to fight against COVID-19 Pandemic
por: Aman, Faseeha, et al.
Publicado: (2020) -
Selective inhibition of RNA polymerase I transcription as a potential approach to treat African trypanosomiasis
por: Kerry, Louise E., et al.
Publicado: (2017) -
Fight against COVID-19 with mRNA vaccines and interaction with Dermal fillers
por: Ghasemi, Shohreh, et al.
Publicado: (2021) -
The therapeutic potential of RNA Polymerase I transcription inhibitor, CX-5461, in uterine leiomyosarcoma
por: Kang, Chang-Won, et al.
Publicado: (2022)